STEM CELLS: THE FUTURE AND THE FACTS
At the Institute for Stem Cell and Regenerative Medicine (ISCRM), researchers are excited and optimistic about the use of stem cells to treat human disease. These special cells provide great promise for creating regenerative therapies where currently none exist. ISCRM scientists are working to develop new approaches to today’s most serious conditions and diseases.
Right now, the bone marrow transplant remains the only FDA approved stem cell treatment available at this time. It involves the use of blood stem cells and umbilical cord stem cells to treat individuals with blood cancers such as leukemia. It took decades to develop and demonstrate the safety and efficacy of this procedure. While ISCRM scientists and researchers are on the brink of new discoveries that may soon change how we confront chronic diseases impacting the heart, brain, kidneys, and pancreas, we want to caution the public to be aware of the current limits of stem cell medicine. Please read more below.